Zanaflex reduces spasticity in MS and after spinal cord injury. Athena Neurosciences, Contact Athena for drug information. Relapsing-Remitting Multiple Sclerosis Study terminated, 1997. Linomide reduced clinical and MRI activity in MS, but caused heart attacks. Pharmacia Terbutaline in Chronic Progressive Multiple Sclerosis Study completed, 1995.
Drug is available.
Data being analyzed. Effects of Zanaflex on spasticity and blood pressure. Trials in planning stages for multiple sclerosis include interferon therapy, T cell receptor vaccination, blockade of costimulatory molecules, chemotherapy, and removal of peripheral lymphocytes. There is ongoing clinical and laboratory research with many of these trials. Laboratory research volunteers are welcome.